Nano-X Imaging Ltd. (NNOX)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 0 | 1 | 9 | 10 | 11 | 13 | 16 | 20 |
| Operating profit | $m | -61 | -102 | ||||||
| Net profit | $m | -43 | -62 | -105 | -61 | -54 | -75 | -117 | -82 |
| EPS reported | $ | -1.16 | -1.70 | ||||||
| Operating cashflow per share | $ | -0.63 | -0.65 | ||||||
| Capex per share | $ | 0.06 | 0.08 | ||||||
| FCF per share | $ | -0.69 | -0.73 | ||||||
| Free cash flow | $m | -45 | -53 | ||||||
| Net debt | $m | -56 | -28 | ||||||
| Book value equity | $m | 140 | 72 | ||||||
| Book value per share | $ | 2.16 | 1.04 | ||||||
| Number of shares | m | 64.79 | 69.93 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 1.30 | 2.50 | ||||||
| P/S LTM | x | 13.93 | 11.60 | ||||||
| P/FCF LTM | x | -4.03 | -3.40 | ||||||
| EV/EBITDA LTM | x | -2.86 | -1.54 | ||||||
| EV/Sales LTM | x | 10.76 | 2.29 | ||||||
| Earnings Yield LTM | % | -41.35% | -1.09% | ||||||
| FCF Yield | % | -24.81% | -29.37% | ||||||
| Quality | |||||||||
| ROE | % | -53.69% | -51.88% | ||||||
| ROIC | % | -39.69% | -44.33% | ||||||
| Operating margin | % | -4.66% | -4.23% | ||||||
| Gross margin | % | -98.21% | -85.67% | ||||||
| FCF/Sales | % | -345.60% | -351.77% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +15.40% | +38.55% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -5.73 | -6.90 | ||||||
| Net Debt/EBITDA | x | 0.84 | 0.73 | ||||||
| EBIT/Net interest | x | 0.00 | -412.07 | ||||||
| Net debt/market cap | % | +1.73% | +4.28% | ||||||
| Net debt/Equity | x | -0.40 | -0.39 | ||||||
| Gross debt/equity | x | 0.06 | 0.11 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free